{"date":"2025-03-27","count":37,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6617-2025-03-27-2001-fkoc0h","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2025-03-27","time":"20:01:30","subject":"代子公司共信醫藥科技股份有限公司公告，經美國ASCO官方電子郵件通知核准：甲苯磺醯胺注射液 (PTS)於惡性肋膜積液之療效研究，投稿摘要已獲准發表於2025 ASCO年會論文總集。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2025-03-27 20:01，「代子公司共信醫藥科技股份有限公司公告，經美國ASCO官方電子郵件通知核准：甲苯磺醯胺注射液 (PTS)於惡性肋膜積液之療」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2025-03-27-2001-1398rkn","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2025-03-27","time":"20:01:21","subject":"代子公司共信醫藥科技股份有限公司公告，甲苯磺酉先胺注射液於治療惡性肋膜積液之療效之回溯性研究取得臺北榮民總醫院人體試驗委員會臨床試驗研究結案同意書。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2025-03-27 20:01，「代子公司共信醫藥科技股份有限公司公告，甲苯磺酉先胺注射液於治療惡性肋膜積液之療效之回溯性研究取得臺北榮民總醫院人體試驗委」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2025-03-27-1929-hn4l9c","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-27","time":"19:29:17","subject":"公告本公司董事會通過113年度合併財報","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-03-27 19:29，「公告本公司董事會通過113年度合併財報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2025-03-27-1928-p67uuk","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-27","time":"19:28:44","subject":"公告本公司內部稽核主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-03-27 19:28，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2025-03-27-1927-ke1qih","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-27","time":"19:27:49","subject":"公告本公司更換主辦輔導推薦證券商事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-03-27 19:27，「公告本公司更換主辦輔導推薦證券商事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2025-03-27-1927-tulf6t","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-27","time":"19:27:25","subject":"公告本公司董事會決議召開114年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-03-27 19:27，「公告本公司董事會決議召開114年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2025-03-27-1926-1tmi5dt","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-27","time":"19:26:44","subject":"公告本公司董事會決議通過113年度員工及董事酬勞","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-03-27 19:26，「公告本公司董事會決議通過113年度員工及董事酬勞」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2025-03-27-1926-ldk656","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-27","time":"19:26:00","subject":"公告本公司董事會決議113年下半年度股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-03-27 19:26，「公告本公司董事會決議113年下半年度股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2025-03-27-1835-1jm8xii","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2025-03-27","time":"18:35:16","subject":"公告本公司一年內累積處分同一有價證券達實收資本額百分之二十","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2025-03-27 18:35，「公告本公司一年內累積處分同一有價證券達實收資本額百分之二十」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2025-03-27-1832-2iz4hx","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2025-03-27","time":"18:32:43","subject":"公告本公司董事會決議不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2025-03-27 18:32，「公告本公司董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2025-03-27-1829-1wpp3mb","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2025-03-27","time":"18:29:44","subject":"公告本公司董事會決議擬辦理私募普通股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2025-03-27 18:29，「公告本公司董事會決議擬辦理私募普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2025-03-27-1829-pxriv","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2025-03-27","time":"18:29:05","subject":"公告本公司董事會決議不繼續辦理113年度股東常會通過之私募普通股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2025-03-27 18:29，「公告本公司董事會決議不繼續辦理113年度股東常會通過之私募普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2025-03-27-1827-tulf6t","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2025-03-27","time":"18:27:43","subject":"公告本公司董事會決議召開114年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2025-03-27 18:27，「公告本公司董事會決議召開114年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2025-03-27-1826-5rax5d","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2025-03-27","time":"18:26:49","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2025-03-27 18:26，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2025-03-27-1825-kmy10s","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2025-03-27","time":"18:25:46","subject":"公告本公司董事會通過113年度個別財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2025-03-27 18:25，「公告本公司董事會通過113年度個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-03-27-1810-18rc4b4","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-03-27","time":"18:10:48","subject":"代重要子公司Alvogen Korea Holdings Ltd.公告2025年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-03-27 18:10，「代重要子公司Alvogen Korea Holdings Ltd.公告2025年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-03-27-1810-1jcsozg","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-03-27","time":"18:10:28","subject":"代重要子公司Alvogen Korea Co., Ltd.公告2025年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-03-27 18:10，「代重要子公司Alvogen Korea Co., Ltd.公告2025年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-03-27-1757-adg5sl","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-03-27","time":"17:57:28","subject":"公告本公司董事會決議與關係人簽定買賣契約","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-03-27 17:57，「公告本公司董事會決議與關係人簽定買賣契約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-03-27-1757-bwopfv","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-03-27","time":"17:57:18","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-03-27 17:57，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-03-27-1757-pi464n","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-03-27","time":"17:57:07","subject":"公告本公司董事會通過114年股東會召開相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-03-27 17:57，「公告本公司董事會通過114年股東會召開相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-03-27-1756-5rax5d","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-03-27","time":"17:56:58","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-03-27 17:56，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-03-27-1756-kmy10s","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-03-27","time":"17:56:48","subject":"公告本公司董事會通過113年度個別財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-03-27 17:56，「公告本公司董事會通過113年度個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2025-03-27-1733-1hw5atl","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-27","time":"17:33:55","subject":"本公司董事會通過召開114年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2025-03-27 17:33，「本公司董事會通過召開114年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2025-03-27-1732-17xrkmm","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-27","time":"17:32:53","subject":"本公司民國113年度合併財務報告業經提報董事會。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2025-03-27 17:32，「本公司民國113年度合併財務報告業經提報董事會。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2025-03-27-1731-gzkpfw","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-27","time":"17:31:45","subject":"本公司董事會決議不分派員工酬勞及董監事酬勞","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2025-03-27 17:31，「本公司董事會決議不分派員工酬勞及董監事酬勞」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2025-03-27-1731-2iz4hx","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-27","time":"17:31:09","subject":"公告本公司董事會決議不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2025-03-27 17:31，「公告本公司董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-03-27-1516-ps7z81","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-03-27","time":"15:16:24","subject":"公告本公司獨立董事辭任功能性委員會職務","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-03-27 15:16，「公告本公司獨立董事辭任功能性委員會職務」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-03-27-1515-qrsqda","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-03-27","time":"15:15:25","subject":"公告本公司獨立董事辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-03-27 15:15，「公告本公司獨立董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2025-03-27-1501-2n9810","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2025-03-27","time":"15:01:55","subject":"公告本公司董事會通過與群聯電子股份有限公司成立合資公司","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2025-03-27 15:01，「公告本公司董事會通過與群聯電子股份有限公司成立合資公司」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2025-03-27-1501-17eszdt","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2025-03-27","time":"15:01:36","subject":"本公司「EFAI NEUROSUITE CT MIDLINE SHIFT ASSESSMENTSYSTEM」獲得衛生福利部食品藥物管理署(TFDA)醫療器材許可證核准通知","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2025-03-27 15:01，「本公司「EFAI NEUROSUITE CT MIDLINE SHIFT ASSESSMENTSYSTEM」獲得衛生福利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2025-03-27-1501-1s5ilpi","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2025-03-27","time":"15:01:14","subject":"公告本公司因會計師事務所內部調整更換會計師","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2025-03-27 15:01，「公告本公司因會計師事務所內部調整更換會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2025-03-27-1342-1eaiuug","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2025-03-27","time":"13:42:52","subject":"公告本公司董事會決議委任薪資報酬委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2025-03-27 13:42，「公告本公司董事會決議委任薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2025-03-27-1342-6x4wji","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2025-03-27","time":"13:42:18","subject":"公告本公司新選任審計委員會名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2025-03-27 13:42，「公告本公司新選任審計委員會名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2025-03-27-1341-9769qc","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2025-03-27","time":"13:41:35","subject":"公告本公司董事會選任董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2025-03-27 13:41，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2025-03-27-1341-1g6xi32","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2025-03-27","time":"13:41:06","subject":"公告本公司114年第一次股東臨時會決議解除新任董事競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2025-03-27 13:41，「公告本公司114年第一次股東臨時會決議解除新任董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2025-03-27-1340-763je","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2025-03-27","time":"13:40:24","subject":"公告本公司114年第一次股東臨時會董事全面改選當選名單暨董事變動達三分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2025-03-27 13:40，「公告本公司114年第一次股東臨時會董事全面改選當選名單暨董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2025-03-27-1336-ub84r7","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2025-03-27","time":"13:36:09","subject":"公告本公司114年第一次股東臨時會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2025-03-27 13:36，「公告本公司114年第一次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}